Celecoxib and Methotrexate

The combination of celecoxib and methotrexate is used in various therapeutic contexts, particularly in cancer treatment and rheumatoid arthritis management. This drug combination has specific interactions and mechanisms that are important to understand. ## Therapeutic Applications ### Metronomic Chemotherapy for Cancer The combination of low-dose methotrexate and celecoxib is used as a metronomic chemotherapy (MCT) approach, particularly for head and neck squamous cell carcinoma. This treatment modality works through several mechanisms: - Modulation of immune response - Inhibition of angiogenesis (new blood vessel formation) - Direct cytotoxic action against cancer cells[1] Clinical studies have shown this combination to be effective in delaying tumor progression in patients with head and neck squamous cell carcinoma in both curative and palliative settings[1]. It's considered an effective, economical, and well-tolerated regimen that provides good pain control with a low toxicity profile for patients with locally advanced cancer[6]. ### Rheumatoid Arthritis Management Both medications are commonly used in rheumatoid arthritis treatment, though their concurrent use requires careful monitoring due to potential interactions. ## Safety Considerations and Interactions ### Liver Fibrosis Risk Concurrent use of methotrexate and celecoxib increases the risk of silent liver fibrosis, particularly in rheumatoid arthritis patients with subclinical reduced kidney function[2]. A study found that patients with lower estimated glomerular filtration rates (eGFRs) had significantly higher risks for developing silent liver fibrosis when taking these medications together[2]. ### Methotrexate Toxicity Celecoxib can affect how methotrexate is cleared from the body: - Celecoxib can slow the kidneys' ability to clear methotrexate - This may cause methotrexate levels in the body to rise - Increased methotrexate levels can lead to toxicity[5] Symptoms of methotrexate toxicity include nausea, vomiting, mouth ulcers, hair loss, dizziness, fever, trouble focusing, headache, and muscle pain[5]. ### Monitoring Requirements When these medications are used together, healthcare providers typically recommend: - More frequent methotrexate blood tests - Regular monitoring of liver function - Assessment of kidney function[5][7] Despite these concerns, the combination can generally be used together with appropriate monitoring and dose adjustments as needed[7]. The combination of celecoxib and methotrexate represents an important therapeutic option, particularly in cancer care where it's being studied for recurrent metastatic oral cavity cancer[4], but requires careful clinical management to mitigate potential risks.